✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

JFL Life Sciences Ltd.

JFLLIFE

Market Cap
₹54 Cr.
P/E
13.09

JFL Life Sciences Ltd.

  • JFL Life Sciences
  • Dipna Pharma.
  • Deccan Health Care
FAQs on JFL Life Sciences Ltd. Shareprice

JFL Life Sciences has given better returns compared to its competitors.
JFL Life Sciences has grown at ~8.86% over the last 2yrs while peers have grown at a median rate of 5.12%

JFL Life Sciences is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of JFL Life Sciences is 12.54, while 3 year average PE is 21.59.
Also latest EV/EBITDA of JFL Life Sciences is 13.37 while 3yr average is 12.96.

View FAQ's On Business
Growth Table
  • JFL Life Sciences Ltd.
  • Dipna Pharma.
  • Deccan Health Care
Balance Sheet
  • JFL Life Sciences Ltd.
  • Dipna Pharma.
  • Deccan Health Care
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • JFL Life Sciences Ltd.
  • Dipna Pharma.
  • Deccan Health Care
Cash Flow
  • JFL Life Sciences Ltd.
  • Dipna Pharma.
  • Deccan Health Care
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • JFL Life Sciences Ltd.
  • Dipna Pharma.
  • Deccan Health Care
Quarterly Results
  • JFL Life Sciences Ltd.
  • Dipna Pharma.
  • Deccan Health Care
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on JFL Life Sciences Ltd. Financials

Balance sheet of JFL Life Sciences is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of JFL Life Sciences is increasing.
Latest net debt of JFL Life Sciences is ₹10.53 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹5.65 Crs.

The profit is oscillating.
The profit of JFL Life Sciences is ₹2.31 Crs for TTM, ₹3.31 Crs for Mar 2024 and ₹2.81 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
JFL Life Sciences latest dividend payout ratio is 8.31% and 3yr average dividend payout ratio is 8.31%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech